AN ACT relating to the promotion of organ and bone marrow donation.
Impact
If enacted, HB 47 will affect the tax code by allowing employers to claim a tax credit equal to the compensation paid to employees during the donation leave period. This could incentivize more employers to support employees who wish to become living donors, ultimately aiming to enhance public awareness about organ donation and generate a positive impact on the state's health care system. The Department of Revenue will monitor and report on the effectiveness of this credit, focusing on the number of returns claiming it and the total credits used over time.
Summary
House Bill 47, also known as the Living Organ and Bone Marrow Donor Assistance Act, introduces provisions aimed at promoting organ and bone marrow donation in Kentucky. The bill establishes a nonrefundable tax credit for employers who grant paid leave to employees serving as living donors. This credit is intended to alleviate the economic burden on employees who want to donate organs or bone marrow, thereby promoting public health and increasing the number of living donors in the state. The act applies to taxable years beginning from January 1, 2022, to January 1, 2026.
Sentiment
The sentiment surrounding HB 47 appears generally positive among advocates for organ and bone marrow donations. Supporters argue that such incentives can significantly increase donor numbers while helping employees avoid economic hardship from taking time off work for donation purposes. Legislators emphasize the importance of promoting health and saving lives through enhanced donation practices, reflecting a collective prioritization of public welfare over bureaucratic hurdles.
Contention
Despite the overall support, there may be concerns regarding the fiscal implications of the bill. Skeptics could argue about the potential tax revenue loss due to the proposed credits and whether the state can afford to subsidize these incentives. Additionally, discussions may arise about the adequacy of the credit in meeting the needs of potential donors and ensuring that employers adequately compensate their employees during the leave, without impacting workplace dynamics.
Mandates paid leave by allowing qualified employees to take medical leave to undergo donation procedures, medical tests, and recovery related to being a living organ donor, or bone marrow transplant donor.